21
Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)
Condition(s):Primary Mediastinal Large B-cell LymphomaLast Updated:April 1, 2021Recruiting
B-cell Lymphoma: 2742 Clinical Trials, Page 3 of 275
Hide Studies Not Open or Pending
22
A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma
Condition(s):B-cell LymphomaLast Updated:February 25, 2022Recruiting
23
a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
Condition(s):B Cell LymphomaLast Updated:April 18, 2023Recruiting
24
Study of TG-1801 in Subjects With B-Cell Lymphoma
Condition(s):B-Cell LymphomaLast Updated:June 1, 2023Active, not recruiting
25
Refractory Diffuse Large B-cell Lymphoma
Condition(s):Diffuse Large B-cell LymphomaLast Updated:September 10, 2018Completed
26
Novel Autologou CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma
Condition(s):B Cell LymphomaLast Updated:February 15, 2019Unknown status
27
Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma.
Condition(s):B Cell LymphomaLast Updated:April 26, 2019Unknown status
28
CD19-targeting CAR T Cells for B Cell Lymphoma
Condition(s):B Cell LymphomaLast Updated:July 16, 2020Withdrawn
29
The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.
Condition(s):Diffuse Large B Cell LymphomaLast Updated:June 23, 2022Recruiting
30
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
Condition(s):Lymphomas; B-cell LymphomasLast Updated:April 18, 2023Recruiting